MAY 26, 2020 5:34 PM PDT

Alzheimer's Gene Doubles Risk of Severe COVID-19

WRITTEN BY: Annie Lennon

Researchers from the University of Exeter, England, and the University of Connecticut have found that people carrying faulty gene APOE e4e4 are more likely to have severe symptoms from COVID-19 than those with a different variant. 

The gene has previously been linked to Alzheimer's disease in Caucasian people. Having two faulty copies of the gene, common to 1 in 36 people of European descent, has been known to increase one's risk of Alzheimer's by 15 times, as well as increase one's risk of heart disease. 

For their study, the researchers analyzed data from the UK Biobank study, a collection of health and genetic data of 500,000 people. They found that while most people in the population had not been exposed to the virus, 2.36% of those with European ancestry had the APOE e4e4 gene, whereas 5.13% of those tested positive for COVID-19 had this gene variant. Meanwhile, those with the e3e3 variant of the same gene were less than half as likely to test positive for the virus. 

The researchers concluded that the APOE e4e4 gene's presence might increase one's chances of developing severe COVID-19 symptoms. These results match their previous findings showing that people with dementia are three times as likely than those without to get severe COVID-19 symptoms. 

"This is an exciting result because we might now be able to pinpoint how this faulty gene causes vulnerability to COVID-19. This could lead to new ideas for treatments. It's also important because it shows again that increasing disease risks that appear inevitable with aging might actually be due to specific biological differences, which could help us understand why some people stay active to age 100 and beyond, while others become disabled and die in their sixties." says co-author of the study, Dr. Chia-Ling Kuo. 

Professor David Melzer, lead author if the study, says, "Several studies have now shown that people with dementia are at high risk of developing severe COVID-19. This study suggests that this high risk may not simply be due to the effects of dementia, advancing age or frailty, or exposure to the virus in care homes."


 

Sources: Neuroscience News, Medscape, The Scientist, The Journals of Gerontology 

 

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUN 28, 2021
Neuroscience
New Findings in Mouse Brains Could Improve Neurological Research
JUN 28, 2021
New Findings in Mouse Brains Could Improve Neurological Research
Researchers led by the University of California have found important neurological differences between human and mouse br ...
JUL 08, 2021
Neuroscience
Tooth Loss Linked to Cognitive Decline and Dementia
JUL 08, 2021
Tooth Loss Linked to Cognitive Decline and Dementia
A person’s risk of cognitive decline grows with each tooth lost, says a new study published in JAMDA: The Jou ...
JUL 15, 2021
Cannabis Sciences
Cannabis Terpenes Provide Pain Relief in Mice
JUL 15, 2021
Cannabis Terpenes Provide Pain Relief in Mice
Cannabis terpenes, the part of cannabis plants responsible for its smell and taste, may be able to relieve pain both by ...
AUG 01, 2021
Drug Discovery & Development
New Compound Halts Neurodegeneration in Alzheimer's
AUG 01, 2021
New Compound Halts Neurodegeneration in Alzheimer's
Chemists have synthesized new compounds that can halt neurodegeneration linked to Alzheimer’s and other neurologic ...
AUG 08, 2021
Cell & Molecular Biology
How Stress Can Impact Gene Expression in the Brain
AUG 08, 2021
How Stress Can Impact Gene Expression in the Brain
University of Bristol researchers have learned more about how chronic stress may be linked to health problems, both phys ...
SEP 07, 2021
Health & Medicine
Vaccines- a Long History of Cost-Benefit Analysis
SEP 07, 2021
Vaccines- a Long History of Cost-Benefit Analysis
Vaccination and new treatments for diseases have remained topics of skepticism since their inception. When it came to an ...
Loading Comments...